Latest Period
Q4 2025
CUSIP: 75120L100
Latest Period
Q4 2025
Institutions Reporting
44
Shares (Excl. Options)
24,166,490
Price
$0.69
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
Latest holder context comes from 44 institutions filings for Q4 2025.
What is CUSIP 75120L100?
CUSIP 75120L100 identifies RLYB - Rallybio Corp - Common Stock, $0.0001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 75120L100:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 10% | $2,897,379 | 4,222,969 | VIKING GLOBAL INVESTORS LP | 31 Dec 2025 | |||
| FMR LLC | 4.3% | $441,675 | 1,766,701 | FMR LLC | 31 Dec 2024 | |||
| TPG GP A, LLC | 7.2% | $219,560 | 378,551 | TPG GP A, LLC | 01 Mar 2026 | |||
| JOHNSON & JOHNSON | 2.9% | $88,683 | 152,901 | Johnson & Johnson | 31 Mar 2026 |
As of 31 Dec 2025, 44 institutional investors reported holding 24,166,490 shares of Rallybio Corp - Common Stock, $0.0001 par value (RLYB). This represents 458% of the company’s total 5,272,448 outstanding shares.
The largest institutional shareholders of Rallybio Corp - Common Stock, $0.0001 par value (RLYB) together control 456% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 80% | 4,194,777 | 0% | 0.01% | $2,878,037 |
| JOHNSON & JOHNSON | 69% | 3,636,363 | 0% | 0.45% | $2,494,909 |
| 5AM Venture Management, LLC | 69% | 3,630,724 | 0% | 0.78% | $2,491,040 |
| TPG GP A, LLC | 57% | 3,028,414 | 0% | 0.08% | $2,089,606 |
| Pivotal bioVenture Partners Investment Advisor LLC | 46% | 2,404,644 | 0% | 0.64% | $1,649,586 |
| FMR LLC | 32% | 1,694,388 | 0% | 0% | $1,162,520 |
| Almitas Capital LLC | 29% | 1,529,653 | -0.59% | 0.23% | $1,049,495 |
| VANGUARD GROUP INC | 19% | 1,016,249 | +1.7% | 0% | $697,147 |
| RENAISSANCE TECHNOLOGIES LLC | 16% | 835,692 | +17% | 0% | $573,368 |
| Canaan Partners XI LLC | 8.5% | 450,000 | 0% | 0.23% | $308,700 |
| Mariner, LLC | 7.7% | 404,546 | 0% | 0% | $277,559 |
| CITADEL ADVISORS LLC | 4.8% | 253,842 | -42% | 0% | $174,161 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.7% | 248,005 | +1.2% | 0% | $170,191 |
| BlackRock, Inc. | 2.7% | 141,663 | 0% | 0% | $97,195 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.9% | 100,724 | -26% | 0% | $69,107 |
| XTX Topco Ltd | 1.8% | 97,313 | +65% | 0% | $66,766 |
| ACADIAN ASSET MANAGEMENT LLC | 1.6% | 83,480 | -7.5% | 0% | $56,000 |
| STATE STREET CORP | 1.2% | 62,072 | 0% | 0% | $42,588 |
| Rangeley Capital, LLC | 0.76% | 40,000 | -52% | 0.02% | $27,444 |
| NORTHERN TRUST CORP | 0.72% | 38,124 | 0% | 0% | $26,157 |
| TWO SIGMA INVESTMENTS, LP | 0.7% | 37,000 | +72% | 0% | $25,386 |
| PRUDENTIAL FINANCIAL INC | 0.55% | 29,100 | -24% | 0% | $19,966 |
| Virtu Financial LLC | 0.51% | 27,132 | -31% | 0% | $19,000 |
| HRT FINANCIAL LP | 0.41% | 21,387 | -34% | 0% | $14,000 |
| OneDigital Investment Advisors LLC | 0.38% | 20,000 | 0% | 0% | $13,722 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$13,484 | $0.58 | 0 |
| 2025 Q4 | 24,166,490 | $16,590,283 | -$46,693 | $0.69 | 44 |
| 2025 Q3 | 28,293,762 | $14,121,676 | -$1,021,666 | $0.50 | 45 |
| 2025 Q2 | 31,192,738 | $10,521,574 | -$558,784 | $0.34 | 48 |
| 2025 Q1 | 32,001,262 | $20,918,290 | -$325,165 | $0.65 | 47 |
| 2024 Q4 | 32,428,353 | $31,130,298 | -$372,186 | $0.96 | 49 |
| 2024 Q3 | 31,212,752 | $36,517,099 | -$480,838 | $1.17 | 49 |
| 2024 Q2 | 31,632,749 | $42,387,896 | +$1,547,544 | $1.34 | 64 |
| 2024 Q1 | 30,198,382 | $55,866,389 | -$3,948,463 | $1.85 | 59 |
| 2023 Q4 | 31,751,116 | $75,885,524 | +$1,489,758 | $2.39 | 53 |
| 2023 Q3 | 31,203,619 | $105,155,071 | -$1,411,692 | $3.37 | 58 |
| 2023 Q2 | 33,260,971 | $188,259,076 | +$6,505,885 | $5.66 | 57 |
| 2023 Q1 | 32,110,359 | $183,344,535 | -$1,268,660 | $5.71 | 51 |
| 2022 Q4 | 32,312,322 | $212,289,584 | +$34,532,833 | $6.57 | 55 |
| 2022 Q3 | 27,791,116 | $402,136,609 | +$2,162,886 | $14.47 | 50 |
| 2022 Q2 | 27,659,695 | $208,831,000 | -$776,317 | $7.55 | 44 |
| 2022 Q1 | 27,776,100 | $193,896,000 | +$124,771 | $6.98 | 47 |
| 2021 Q4 | 26,674,067 | $252,852,000 | +$1,365,608 | $9.54 | 37 |
| 2021 Q3 | 24,054,356 | $419,896,000 | +$419,896,000 | $17.58 | 33 |